The goal in the world of global health is to bring an end to this scourge by 2030. A new drug looks as if it could do the job ...

On-track to report top-line data in the fall of 2026 from the pivotal Phase 3 OPERA-01 trial of palazestrant as a monotherapy in patients with 2/3L ER+/HER2- metastatic breast cancerAdvanced ...

Explainability tools are commonly used in AI development to provide visibility into how models interpret data. In healthcare machine learning systems, explainability techniques may highlight factors ...

GLENDALE, CA - March 16, 2026 - LigoLab, a laboratory informatics company headquartered in Glendale, reported key ...

LTR Pharma recently announced the dosing of the first patients in the Phase II study of SPONTAN ®, which is evaluating the safety, tolerability and pharmacokinetic profile of LTR Pharma’s rapid acting ...

Alto Neuroscience secures $120M to advance novel depression therapy ALTO-207 through Phase 3 trials, aiming for FDA ...

Nelson Fernandez and B&N Talent Partners Joins the Dimensional Search Network of Offices B&N Talent Partners, an executive ...

Rhythm Pharma (RYTM) surges on IMCIVREE sales growth and TRANSCEND data ahead of the March 20 FDA PDUFA decision—see risks, ...

ORLANDO, FL, UNITED STATES, March 16, 2026 /EINPresswire.com/ -- Orlando Leader Champions Maternal and Neonatal Care, ...

Early clinical proof-of-concept for WEE1 inhibitor APR-1051 in the ongoing ACESOT-1051 trial with two partial responders at first scan in endometrial cancer patients with PPP2R1A mutationClinical team ...

As AI capabilities integrate more deeply into enterprise operations, the conversation has expanded to include governance, ...

Founded to develop patient-centred, steroid-free by design skincare products for individuals suffering from chronic psoriasis ...